PTGX ææ°ååæã®æ±ºç®å ±åæž
çºè¡šæ¥8/5/2026
EPSå®çžŸïŒUSDïŒ2.47
売äžé«å®çžŸïŒUSDïŒ213.47M
Protagonist Therapeutics Incã®æ±ºç®æ¥ã»å ±åæž
ãã®ããŒãžã§ã¯ãææ°ã® Protagonist Therapeutics Inc ã®æ±ºç®å ±åæžã次å Protagonist Therapeutics Inc ã®æ±ºç®äºå®æ¥ãéå»ã®ããŒã¿ãProtagonist Therapeutics Inc ã®æ±ºç®é»è©±äŒè°ãã¥ãŒã¹ãªã©ã詳现㪠Protagonist Therapeutics Inc ã®æ±ºç®ããŒã¿ãæäŸããŠããŸãã
PTGX 次åååæã®æ±ºç®çºè¡šæ¥
çºè¡šæ¥--
EPSäºæ³ïŒUSDïŒ--
売äžé«äºæ³ïŒUSDïŒ--
PTGX FY2025 決ç®
EPS (å幎åææ¯)-2.05-145.80%
売äžé« (å幎åææ¯)46.02M-89.41%
Protagonist Therapeutics IncïŒPTGXïŒã®æ±ºç®å±¥æŽ
| å ¬éæ¥ | 察象æéçµäº | EPS/äºæž¬ | åç/äºæž¬ | EPSãµãã©ã€ãº % | 売äžé«ãµãã©ã€ãº % |
|---|---|---|---|---|---|
| 11/5/2026 | 09/2026 | 3.32/2.44 | 274.41M/238.47M | 35.76% | 15.07% |
| 8/5/2026 | 06/2026 | 2.47/2.08 | 213.47M/203.76M | 18.62% | 4.77% |
| 5/5/2026 | 03/2026 | 0.06/-0.53 | 56.37M/16.27M | 110.91% | 246.39% |
| 2/25/2026 | 12/2025 | -0.69/-0.49 | 7.44M/8.93M | -41.88% | -16.68% |
| 11/6/2025 | 09/2025 | -0.62/-0.64 | 4.71M/3.64M | 3.46% | 29.58% |
| 8/6/2025 | 06/2025 | -0.55/-0.58 | 5.55M/6.81M | 5.35% | -18.51% |
| 5/6/2025 | 03/2025 | -0.19/-0.23 | 28.32M/30.44M | 19.90% | -6.97% |
| 2/21/2025 | 12/2024 | 2.11/0.32 | 170.64M/50.35M | 557.84% | 238.88% |